Free Trial

Diaceutics (DXRX) Competitors

Diaceutics logo
GBX 160 -2.00 (-1.23%)
As of 08:42 AM Eastern

DXRX vs. YGEN, ABDX, VRCI, GENI, AGL, PRM, GDR, IDHC, DMTR, and LLAI

Should you be buying Diaceutics stock or one of its competitors? The main competitors of Diaceutics include Yourgene Health (YGEN), Abingdon Health (ABDX), Verici Dx (VRCI), GENinCode (GENI), ANGLE (AGL), Proteome Sciences (PRM), genedrive (GDR), Integrated Diagnostics (IDHC), Deepmatter Group (DMTR), and LungLife AI (LLAI). These companies are all part of the "diagnostics & research" industry.

Diaceutics vs. Its Competitors

Yourgene Health (LON:YGEN) and Diaceutics (LON:DXRX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends, valuation and media sentiment.

23.3% of Yourgene Health shares are owned by institutional investors. Comparatively, 32.2% of Diaceutics shares are owned by institutional investors. 64.4% of Yourgene Health shares are owned by company insiders. Comparatively, 26.3% of Diaceutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Diaceutics has higher revenue and earnings than Yourgene Health. Diaceutics is trading at a lower price-to-earnings ratio than Yourgene Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Yourgene Health£29.67M0.00-£8.17M-£0.01N/A
Diaceutics£34.40M3.94-£2.84M-£0.02-8,888.89

In the previous week, Diaceutics had 1 more articles in the media than Yourgene Health. MarketBeat recorded 1 mentions for Diaceutics and 0 mentions for Yourgene Health. Diaceutics' average media sentiment score of 1.11 beat Yourgene Health's score of 0.00 indicating that Diaceutics is being referred to more favorably in the news media.

Company Overall Sentiment
Yourgene Health Neutral
Diaceutics Positive

Diaceutics has a net margin of -10.90% compared to Yourgene Health's net margin of -27.55%. Diaceutics' return on equity of -7.15% beat Yourgene Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Yourgene Health-27.55% -27.06% -6.71%
Diaceutics -10.90%-7.15%-6.06%

Diaceutics has a consensus target price of GBX 175, suggesting a potential upside of 9.38%. Given Diaceutics' stronger consensus rating and higher probable upside, analysts plainly believe Diaceutics is more favorable than Yourgene Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Yourgene Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Diaceutics
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Yourgene Health has a beta of 0.86, suggesting that its stock price is 14% less volatile than the S&P 500. Comparatively, Diaceutics has a beta of 0.58, suggesting that its stock price is 42% less volatile than the S&P 500.

Summary

Diaceutics beats Yourgene Health on 11 of the 15 factors compared between the two stocks.

Get Diaceutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for DXRX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DXRX vs. The Competition

MetricDiaceuticsDiagnostics & Research IndustryMedical SectorLON Exchange
Market Cap£135.38M£51.31M£6.08B£2.56B
Dividend YieldN/A3.87%5.73%5.32%
P/E Ratio-8,888.890.9984.694,392.87
Price / Sales3.94545.20596.0499,529.17
Price / Cash3.1211.4237.8627.90
Price / Book3.492.7912.288.16
Net Income-£2.84M£334.07B£3.32B£5.89B
7 Day Performance-1.23%0.12%1.30%-0.56%
1 Month Performance10.73%-7.31%8.49%1.40%
1 Year Performance20.30%-0.06%72.74%136.87%

Diaceutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DXRX
Diaceutics
1.3576 of 5 stars
GBX 160
-1.2%
GBX 175
+9.4%
+20.8%£135.38M£34.40M-8,888.89151Positive News
YGEN
Yourgene Health
N/AN/AN/AN/A£16.43M£29.67M-51.50253
ABDX
Abingdon Health
N/AGBX 5.89
-1.9%
N/A-30.6%£11.40M£6.82M-806.1684
VRCI
Verici Dx
N/AGBX 0.65
-7.1%
N/A-80.5%£9.84M£1.91M-22.4119Negative News
Gap Down
GENI
GENinCode
N/AGBX 3.28
-8.9%
N/A-24.3%£9.41M£2.91M-139.572,300Gap Down
AGL
ANGLE
1.9185 of 5 stars
GBX 2.38
+25.0%
GBX 40
+1,584.2%
-77.5%£7.66M£2.62M-49.48650News Coverage
Gap Down
High Trading Volume
PRM
Proteome Sciences
N/AGBX 1.91
+3.5%
N/A-32.2%£5.64M£4.53M-168.94240Gap Up
GDR
genedrive
N/AGBX 0.36
+44.9%
N/A-78.9%£3.64M£676K-16.4443High Trading Volume
IDHC
Integrated Diagnostics
N/AGBX 0.46
-1.7%
N/A+24.4%£2.67M£5.72B0.256,692Gap Down
DMTR
Deepmatter Group
N/AN/AN/AN/A£1.33M£1.04M-0.11N/AGap Down
LLAI
LungLife AI
N/AGBX 3.50
-17.6%
N/A-63.6%£1.16M£33.87K-0.2815Gap Down
High Trading Volume

Related Companies and Tools


This page (LON:DXRX) was last updated on 10/17/2025 by MarketBeat.com Staff
From Our Partners